RETA

Reata Pharmaceuticals, Inc. Class A Common Stock

Delisted

RETA was delisted on the 25th of September, 2023.

52 hedge funds and large institutions have $125M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 8 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$73.5M
2
$7.14M
3
$5.46M
4
$5.01M
5
$4.01M
6
$3.69M
7
$3.17M
8
$3.12M
9
$2.83M
10
$2.19M
11
$1.97M
12
$1.38M
13
$1.19M
14
$1.17M
15
$1.09M
16
$1.03M
17
$951K
18
$568K
19
$497K
20
$493K
21
$481K
22
$411K
23
$411K
24
$380K
25
$369K